Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Multifaceted Role of TGF-β in Gastrointestinal Tumors.
Cancers (Basel). 2021 Aug 5;13(16):3960. doi: 10.3390/cancers13163960.
Cancers (Basel). 2021.
PMID: 34439114
Free PMC article.
Review.
Targeting KRAS: The Elephant in the Room of Epithelial Cancers.
Merz V, Gaule M, Zecchetto C, Cavaliere A, Casalino S, Pesoni C, Contarelli S, Sabbadini F, Bertolini M, Mangiameli D, Milella M, Fedele V, Melisi D.
Merz V, et al. Among authors: sabbadini f.
Front Oncol. 2021 Mar 11;11:638360. doi: 10.3389/fonc.2021.638360. eCollection 2021.
Front Oncol. 2021.
PMID: 33777798
Free PMC article.
Review.
Item in Clipboard
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma.
Pietrobono S, Sabbadini F, Bertolini M, Mangiameli D, De Vita V, Fazzini F, Lunardi G, Casalino S, Scarlato E, Merz V, Zecchetto C, Quinzii A, Di Conza G, Lahn M, Melisi D.
Pietrobono S, et al. Among authors: sabbadini f.
Cancer Res. 2024 Jan 2;84(1):118-132. doi: 10.1158/0008-5472.CAN-23-0104.
Cancer Res. 2024.
PMID: 37738399
Free PMC article.
Clinical Trial.
Item in Clipboard
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.
Santoro R, Zanotto M, Simionato F, Zecchetto C, Merz V, Cavallini C, Piro G, Sabbadini F, Boschi F, Scarpa A, Melisi D.
Santoro R, et al. Among authors: sabbadini f.
Mol Cancer Ther. 2020 Jan;19(1):247-257. doi: 10.1158/1535-7163.MCT-19-0270. Epub 2019 Sep 27.
Mol Cancer Ther. 2020.
PMID: 31562256
Free article.
Item in Clipboard
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer.
Merz V, Zecchetto C, Santoro R, Simionato F, Sabbadini F, Mangiameli D, Piro G, Cavaliere A, Deiana M, Valenti MT, Bazan D, Fedele V, Lonardi S, Melisi D.
Merz V, et al. Among authors: sabbadini f.
Clin Cancer Res. 2020 Sep 1;26(17):4661-4669. doi: 10.1158/1078-0432.CCR-20-0395. Epub 2020 Jun 12.
Clin Cancer Res. 2020.
PMID: 32532788
Clinical Trial.
Item in Clipboard
Cite
Cite